AUGX
Income statement / Annual
Last year (2023), Augmedix, Inc.'s total revenue was $44.86 M,
an increase of 45.01% from the previous year.
In 2023, Augmedix, Inc.'s net income was -$19.17 M.
See Augmedix, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$44.86 M
|
$30.93 M
|
$22.17 M
|
$16.48 M
|
$14.11 M
|
$10.82 M
|
| Cost of Revenue |
$23.33 M |
$16.98 M |
$12.16 M |
$9.69 M |
$9.43 M |
$10.03 M |
| Gross Profit |
$21.53 M |
$13.95 M |
$10.01 M |
$6.79 M |
$4.68 M |
$785,917.00 |
| Gross Profit Ratio |
0.48 |
0.45 |
0.45 |
0.41 |
0.33 |
0.07 |
| Research and Development
Expenses |
$11.18 M
|
$10.15 M
|
$6.68 M
|
$4.52 M
|
$6.98 M
|
$6.96 M
|
| General & Administrative
Expenses |
$18.44 M
|
$16.89 M
|
$13.76 M
|
$11.57 M
|
$10.86 M
|
$13.15 M
|
| Selling & Marketing
Expenses |
$10.69 M
|
$9.28 M
|
$7.51 M
|
$4.40 M
|
$3.58 M
|
$3.59 M
|
| Selling, General &
Administrative Expenses |
$29.13 M
|
$26.18 M
|
$21.27 M
|
$15.97 M
|
$14.44 M
|
$16.75 M
|
| Other Expenses |
$1.00 M |
-$2.08 M |
$87,000.00 |
-$1.91 M |
$1.05 M |
$0.00 |
| Operating Expenses |
$40.31 M |
$36.33 M |
$27.95 M |
$20.49 M |
$21.42 M |
$22.87 M |
| Cost And Expenses |
$63.63 M |
$53.30 M |
$40.10 M |
$30.18 M |
$30.85 M |
$32.90 M |
| Interest Income |
$1.11 M |
$245,000.00 |
$15,000.00 |
$10,835.00 |
$6,268.00 |
$2.08 M |
| Interest Expense |
$2.25 M |
$2.08 M |
$2.50 M |
$1.45 M |
$2.81 M |
$0.00 |
| Depreciation &
Amortization |
$1.10 M
|
$1.53 M
|
$691,000.00
|
$867,000.00
|
$949,006.00
|
$1.59 M
|
| EBITDA |
-$17.68 M
|
-$21.81 M
|
-$14.47 M
|
-$12.83 M
|
-$14.74 M
|
-$21.33 M
|
| EBITDA Ratio |
-0.39 |
-0.72 |
-0.81 |
-0.83 |
-1.04 |
-1.97 |
| Operating Income Ratio
|
-0.42
|
-0.72
|
-0.81
|
-0.83
|
-1.19
|
-2.12
|
| Total Other
Income/Expenses Net |
-$247,000.00
|
-$1.97 M
|
$134,000.00
|
-$1.91 M
|
-$1.76 M
|
-$1.24 M
|
| Income Before Tax |
-$19.03 M |
-$24.45 M |
-$17.85 M |
-$15.60 M |
-$18.50 M |
-$24.16 M |
| Income Before Tax Ratio
|
-0.42
|
-0.79
|
-0.81
|
-0.95
|
-1.31
|
-2.23
|
| Income Tax Expense |
$145,000.00 |
$2.08 M |
-$691,000.00 |
-$867,000.00 |
$3.86 M |
$0.00 |
| Net Income |
-$19.17 M |
-$26.53 M |
-$17.16 M |
-$14.74 M |
-$22.36 M |
-$24.16 M |
| Net Income Ratio |
-0.43 |
-0.86 |
-0.77 |
-0.89 |
-1.59 |
-2.23 |
| EPS |
-0.44 |
-0.71 |
-0.59 |
-2.1 |
-26.89 |
-20.32 |
| EPS Diluted |
-0.44 |
-0.71 |
-0.59 |
-2.1 |
-26.89 |
-20.32 |
| Weighted Average Shares
Out |
$43.95 M
|
$37.42 M
|
$28.91 M
|
$7.03 M
|
$831,590.00
|
$1.19 M
|
| Weighted Average Shares
Out Diluted |
$43.95 M
|
$37.42 M
|
$28.91 M
|
$7.03 M
|
$831,590.00
|
$1.19 M
|
| Link |
|
|
|
|
|
|
